In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Felmingham D, Grüneberg RN. A multicenter collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project. J Antimicrob Chemother1996; 38 (Suppl. A): 1–57.
Pfaller MA, Jones RN, Doern GV et al. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Chemother1998; 42: 1762–70.
Turner PJ, Greenhalgh JM, Edwards JR et al. The MYSTIC (meropenem yearly susceptibility test information collection) programme. Int J Antimicrob Agents1999; 13: 117–25.
Jones RN, Masterton R. Determining the value of antimicrobial surveillance programs. Diagnostic Microbiology and Infectious Disease2001; 41: 171–5.
Felmingham D. The need for antimicrobial resistance surveillance. J Antimicrob Chemother2002; 50 (Suppl. S1): 1–7.
National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically—Sixth Edition: Approved Standard M7-A6. Villanova, PA, USA: NCCLS, 2003.
National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing—Thirteenth Informational Supplement. Supplemental Tables M100-S13. Villanova, PA, USA: NCCLS, 2003.
Cornaglia G, Hryniewicz W, Jarlier V et al. European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect2004; 10: 349–83.
Mazuski JE, Sawyer RG, Nathens AB et al. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg Infect2002; 3: 161–73.
Solomkin JS, Mazuski JE, Baron EJ et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis2003; 37: 997–1005.
Stürenburg E, Mack D. Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect2003; 47: 273–95.
Thompson KS. Controversies about extended-spectrum and AmpC β-lactamases. Emerg Infect Dis2001; 7: 333–6.
Komatsu M, Aihara M, Shimakawa K et al. Evaluation of MicroScan ESBL confirmation panel for Enterobacteriaceae-producing, extended-spectrum β-lactamases isolated in Japan. Diagn Microbiol Infect Dis2003; 46: 125–30.
Stürenburg E, Sobottka I, Noor D et al. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum β-lactamases in an Enterobacteriaceae strain collection. J Antimicrob Chemother2004; 54: 134–8.
Queenan AM, Foleno B, Gownley C et al. Effects of inoculum and β-lactamase activity in AmpC- and extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. J Clin Microbiol2004; 42: 269–75.
Decré D, Burghoffer B, Gautier V et al. Outbreak of multi-resistant Klebsiella oxytoca involving strains with extended-spectrum β-lactamases and strains with extended-spectrum activity of the chromosomal β-lactamase. J Antimicrob Chemother2004; 54: 881–8.
Valverde A, Coque TM, Sanchez-Moreno MP et al. Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol2004; 42: 4769–75.
Cantón R, Oliver A, Coque TM et al. Epidemiology of extended-spectrum β-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period. J Clin Microbiol2002; 40: 1237–43.
Levison ME, Mailapur YV, Pradhan SK et al. Regional occurrence of plasmid-mediated SHV-7, an extended-spectrum β-lactamase, in Enterobacter cloacae in Philadelphia teaching hospitals. Clin Infect Dis2002; 35: 1551–4.
Schwaber MJ, Raney PM, Rasheed JK et al. Utility of NCCLS guidelines for identifying extended-spectrum β-lactamases in non-Escherichia coli and non-Klebsiella spp. of Enterobacteriaceae. J Clin Microbiol2004; 42: 294–8.
Schwaber MJ, De-Medina T, Carmeli Y. Epidemiological interpretation of antibiotic resistance studies—what are we missing? Nat Rev Microbiol2004; 2: 979–83.